A comparison of the sensitivities of adaptive tracking, eye movement analysis, and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers

Abstract

The effects of single oral doses of 5, 10, and 20 mg temazepam were evaluated with the adaptive tracking test, analysis of smooth‐pursuit and saccadic eye movements, and visual analog lines in a placebo‐controlled, double‐blind, crossover experiment with 12 healthy volunteers. Pharmacodynamic testing was performed until 10 hours and pharmacokinetics were evaluated until 24 hours. Temazepam, 20 mg, caused effects in all tests, with peak effects occurring at 30 minutes. The 10 mg dose caused effects on saccadic eye movements and subjective scores of alertness, whereas 5 mg temazepam was detected only by analysis of saccadic eye movements. Linear relationships between plasma concentrations and effects were found in nine subjects for saccadic peak velocity and eight subjects for subjective scores of alertness. The results of this study demonstrate manifest differences in the sensitivities of performance tests and stress the importance of validation of methods when effects of drugs on human performance are studied. Clinical Pharmacology and Therapeutics (1991) 50, 172–180; doi:

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol

“…There was a clear effect of diazepam+alcohol on smooth pursuit, while diazepam or alcohol alone had no apparent effect. This last result is not in accordance with the conclusions of other studies that report impairment of smooth pursuit eye movements with benzodiazepines [13,14].…”

Pharmacokinetic–pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects

“…SPV is one of the most sensitive parameters for alertness [53][54][55]. Adaptive tracking performance is a visuomotor task that is influenced by attention and vigilance.…”

CNS‐related performance and haemodynamics of metoprolol‐Oros and propranolol after single and 3 days dosing in healthy volunteers.

“…There were apparent increases in baseline values both for saccadic peak velocity ( Figure 2) and for subjective alertness (Figure 4). In a previous validation study, these parameters have been shown to be highly sensitive indicators of sedative drug effects, with little variability in baseline values (Steveninck et al, 1991). Possibly, treatment with temazepam on day 1 caused subjects to be more rested and hence more alert on day 3.…”

“…As effects of 10 mg temazepam were limited to changes in saccadic peak velocity, the possibility of a type-II statistical error as well as potential confounding factors should be considered when judging 13-adrenoceptor blocker effects from these results. In a previous study effects of a 10 mg dose of liquid temazepam on saccadic peak velocity, smooth pursuit eye movements and subjective alertness were clearly demonstrated up to 150 min after drug intake, while the effects of 5 mg liquid temazepam on saccadic peak velocity and subjective alertness were just detectable (Steveninck et al, 1991).…”

“…The efficacy of sustained release 3-adrenoceptor blockers, including metoprolol, has been demonstrated in several studies in hypertensive patients (Carruthers et al, 1990;McInnes & Brodie, 1988a;Serlin et al, 1983). Also, subjective tolerability of sustained release metoprolol appears to be similar to or slightly better than conventional ,-adrenoceptor blocker therapy (Dimenas & Dahlof, 1990 (Feliciano et al, 1990 (Dimsdale et al, 1989) (Steveninck et al, 1991 Software Inc., Los Angeles, U.S.A.) which, using a restricted maximum likelihood approach, is capable of analysing such unbalanced data sets. Missing data did not exceed 3% of the total number of observations for any parameter.…”